<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD2960810">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <title>Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Barbara</namePart>
                        <namePart type="family">Kaltschmidt</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Kaya</namePart>
                        <namePart type="family">Witte</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Johannes</namePart>
                        <namePart type="family">Greiner</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0002-0524-662X</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Florian</namePart>
                        <namePart type="family">Weissinger</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Christian</namePart>
                        <namePart type="family">Kaltschmidt</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2022</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Among the cell populations existing within a tumor, cancer stem cells are responsible for metastasis formation and chemotherapeutic resistance. In the present review, we focus on the transcription factor NF-κB, which is present in every cell type including cancer stem cells. NF-κB is involved in pro-tumor inflammation by its target gene interleukin 1 (IL1) and can be activated by a feed-forward loop in an IL1-dependent manner. Here, we summarize current strategies targeting NF-κB by chemicals and biologicals within an integrated cancer therapy. Specifically, we start with a tyrosine kinase inhibitor targeting epidermal growth factor (EGF)-receptor-mediated phosphorylation. Furthermore, we summarize current strategies of multiple myeloma treatment involving lenalidomide, bortezomib, and dexamethasone as potential NF-κB inhibitors. Finally, we discuss programmed death-ligand 1 (PD-L1) as an NF-κB target gene and its role in checkpoint therapy. We conclude, that NF-κB inhibition by specific inhibitors of IκB kinase was of no clinical use but inhibition of upstream and downstream targets with drugs or biologicals might be a fruitful way to treat cancer stem cells.</abstract>
                    <subject>
                        <topic>cancer stem cells</topic>
                        <topic>NF-κB</topic>
                        <topic>EGF</topic>
                        <topic>PD-L1</topic>
                        <topic>lenalidomide</topic>
                        <topic>bortezomib</topic>
                        <topic>dexamethason</topic>
                    </subject>
                    <classification authority="ddc">590</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>Biomedicines</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>10</number>
                            </detail>
                            <detail type="issue">
                                <number>2</number>
                            </detail>
                        </part>
                    </relatedItem>
                    <identifier type="eIssn">2227-9059</identifier>
                    <identifier type="MEDLINE">35203471</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-29608107</identifier>
                    <identifier type="doi">10.3390/biomedicines10020261</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_2960810</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_2960810">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/2960810/2960811/biomedicines-10-00261-v2.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_2960810" DMDID="DMD2960810">
            <mets:fptr FILEID="FILE0_bielefeld_pub_2960810"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
